Exploratory, double blind placebo controlled, randomized, single cross-over study to evaluate the potential anti-oxidant action of Niaspan

Registry ID

EUCTR2006-006889-42

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Faculdade de Ciências Médicas – Universidade Nova de Lisboa

Start date

2007-07-18

Completion date

2011-01-28

Last update

2026-08-16

Conditions

• Hypercholesterolemia

Summary

To evaluate de effect of Niaspan in Paraoxonase activity compared with placebo

Locations

• , , Portugal

Related clinical trials

• A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
• Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
• Causes and Natural History of Dyslipidemias
• A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
• A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
• Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

View on source registry